FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells

被引:0
|
作者
N McInnes
T J Sadlon
C Y Brown
S Pederson
M Beyer
J L Schultze
S McColl
G J Goodall
S C Barry
机构
[1] Women's and Children's Health Research Institute,Department of Paediatrics
[2] Molecular Immunology Laboratory,Department of Immunology
[3] Women's and Children's Hospital,Department of Medicine
[4] The University of Adelaide,Department of Gastroenterology
[5] LIMES-Institute,undefined
[6] Laboratory for Genomics and Immunoregulation,undefined
[7] University of Bonn,undefined
[8] The University of Adelaide,undefined
[9] Centre for Cancer Biology,undefined
[10] SA Pathology,undefined
[11] University of Adelaide,undefined
[12] Women's and Children's Hospital,undefined
来源
Oncogene | 2012年 / 31卷
关键词
SATB1; FOXP3; microRNA; gene regulation networks; breast cancer; tumour suppressor;
D O I
暂无
中图分类号
学科分类号
摘要
The transcription factor FOXP3 has been identified as a tumour suppressor in the breast and prostate epithelia, but little is known about its specific mechanism of action. We have identified a feed-forward regulatory loop in which FOXP3 suppresses the expression of the oncogene SATB1. In particular, we demonstrate that SATB1 is not only a direct target of FOXP3 repression, but that FOXP3 also induces two miRs, miR-7 and miR-155, which specifically target the 3′-UTR of SATB1 to further regulate its expression. We conclude that FOXP3-regulated miRs form part of the mechanism by which FOXP3 prevents the transformation of the healthy breast epithelium to a cancerous phenotype. Approaches aimed at restoring FOXP3 function and the miRs it regulates could help provide new approaches to target breast cancer.
引用
收藏
页码:1045 / 1054
页数:9
相关论文
共 50 条
  • [31] FOXP3 expression in FOXP3+ tumor cells promotes hepatocellular cells metastasis
    Zhang, Henghui
    Chen, Yanhui
    Liao, Weijia
    Wang, Li
    Xie, Xingwang
    Fei, Ran
    Wang, Xueyan
    Mei, Minghui
    Wei, Lai
    Chen, Hongsong
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 5868 - 5881
  • [32] FOXP3 expression in tumor cells and implications for cancer progression
    Triulzi, Tiziana
    Tagliabue, Elda
    Balsari, Andrea
    Casalini, Patrizia
    JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (01) : 30 - 35
  • [33] FoxP3 Expression in Macrophages, Cancer, and B Cells—Is It Real?
    Zahava Vadasz
    Elias Toubi
    Clinical Reviews in Allergy & Immunology, 2017, 52 : 364 - 372
  • [34] Inhibition of Foxp3 in cancer cells induces apoptosis of thyroid cancer cells
    Chu, Ryan
    Liu, Shirley Y. W.
    Vlantis, Alexander C.
    van Hasselt, C. Andrew
    Ng, Enders K. W.
    Fan, Michael Dahua
    Ng, Siu Kwan
    Chan, Amy S. W.
    Du, Jing
    Wei, Wei
    Liu, Xiaoling
    Liu, Zhimin
    Chen, George G.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 399 (0C) : 228 - 234
  • [35] Erratum to: The role of FOXP3 in the development and metastatic spread of breast cancer
    Stephen Douglass
    Simi Ali
    Annette P. Meeson
    David Browell
    John A. Kirby
    Cancer and Metastasis Reviews, 2013, 32 : 763 - 763
  • [36] How Treg cells lose FOXP3
    Nicholas J. Bernard
    Nature Reviews Rheumatology, 2019, 15 : 127 - 127
  • [37] The adaptability of regulatory T cells and Foxp3
    Hori, Shohei
    Murakami, Ryuichi
    INTERNATIONAL IMMUNOLOGY, 2021, 33 (12) : 803 - 807
  • [38] FOXP3 as a master regulator of Treg cells
    Shohei Hori
    Nature Reviews Immunology, 2021, 21 : 618 - 619
  • [39] The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer
    Liu, Luyao
    Xiao, Wang
    Zhang, Chaojie
    Fan, Peizhi
    Zeng, Jie
    Yi, Jianing
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 1233 - 1251
  • [40] FOXP3 activation in Treg cells, - atomic level aspects of FOXP3 structure and biochemistry that govern function
    Li, Bin
    Song, Xiaomin
    Zhou, Zhaocai
    Wang, Qiang
    Shen, Yuan
    Greene, Mark I.
    JOURNAL OF IMMUNOLOGY, 2009, 182